Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples